DESCRIPTION
TITLE OF THE การประดิษฐ์: COMPOSITION CONTAINING
BACTERIUM BELONGING TO จีนัส LACTOBACILLUS 5
TECHNICAL FIELD
[0001] The การประดิษฐ์นี้ relates to a composition containing a
bacterium belonging to the จีนัส Lactobacillus. More specifically, the การประดิษฐ์นี้ relates to a composition containing novel Lactobacillus
10 pentosus.
BACKGROUND ART
[0002] Some of lactic acid bacteria and Bifidobacteria have excellent
physiological activities such as an intestine regulating activity and
15 immunostimulating activity, and have been used in various applications
depending upon the properties of the bacterial สปีชีส์. Among them,
recently, studies on dieting effects by taking these bacteria have been
progressed, and many reports have been made.
[0003] For example, Patent Publication 1 reports that Lactobacillus
20 rhamnosus ATCC53103 strain degrades a lipid (triacyl glycerol) which is
causative of obesity, thereby blocking its absorption into the body. In addition, it has been known that L. brevis KB290, which is one kind of vegetable lactic acid bacteria, reaches to the intestines in a live state, thereby showing excellent intestinal viable rates and intestinal tract
25 survivability (however, the number of bacteria excreted is smaller than the
2
number of ingested bacteria) (see Non-Patent Publication 1). Also, the following Non-Patent Publication 2 has reported that Lactobacillus
acidophilus L-92 strain is collected from feces in an amount 93% of the number of ingested bacteria, so that the strain has excellent intestinal tract
5 survivability, and the following Non-Patent Publication 3 has reported that
the survivability of L. gasseri SBT2055 in the intestinal tract is examined, and 100 g of a fermented milk containing 1 x 106 to 5 x 106 cfu/g of the bacteria is ให้, and as a result, the bacteria are detected from feces maximally at 1 x 105 cfu/g or so.
10 [0004] On the other hand, as to the Bifidobacteria, it has been reported that
Bifidobacterium animalis subสปีชีส์ lactis GCL2505 strain not only has intestinal tract survivability in which the strain reaches to the intestines in a live state after the oral ingestion but also shows remarkable proliferation ability within the intestinal tract (see, Patent Publication 2). The following
15 Non-Patent Publication 4 has reported that when B. animalis ssp. lactis
DN-173 010 is ให้ to adults, 20% or so of the DN-173 010 is
detected from stools, relative to the number of bacteria ingested.
RELATED ART REFERENCES
20 PATENT PUBLICATIONS
[0005] Patent Publication 1: Japanese Patent Laid-Open No. 2011-206057
Patent Publication 2: Japanese Patent Laid-Open No. 2011-172506
NON-PATENT PUBLICATIONS
DESCRIPTIONTITLE OF THE การประดิษฐ์: COMPOSITION CONTAINING BACTERIUM BELONGING TO จีนัส LACTOBACILLUS 5TECHNICAL FIELD[0001] The การประดิษฐ์นี้ relates to a composition containing abacterium belonging to the จีนัส Lactobacillus. More specifically, the การประดิษฐ์นี้ relates to a composition containing novel Lactobacillus10 pentosus.BACKGROUND ART[0002] Some of lactic acid bacteria and Bifidobacteria have excellentphysiological activities such as an intestine regulating activity and15 immunostimulating activity, and have been used in various applicationsdepending upon the properties of the bacterial สปีชีส์. Among them,recently, studies on dieting effects by taking these bacteria have beenprogressed, and many reports have been made.[0003] For example, Patent Publication 1 reports that Lactobacillus20 rhamnosus ATCC53103 strain degrades a lipid (triacyl glycerol) which iscausative of obesity, thereby blocking its absorption into the body. In addition, it has been known that L. brevis KB290, which is one kind of vegetable lactic acid bacteria, reaches to the intestines in a live state, thereby showing excellent intestinal viable rates and intestinal tract25 survivability (however, the number of bacteria excreted is smaller than the 2number of ingested bacteria) (see Non-Patent Publication 1). Also, the following Non-Patent Publication 2 has reported that Lactobacillus acidophilus L-92 strain is collected from feces in an amount 93% of the number of ingested bacteria, so that the strain has excellent intestinal tract5 survivability, and the following Non-Patent Publication 3 has reported thatthe survivability of L. gasseri SBT2055 in the intestinal tract is examined, and 100 g of a fermented milk containing 1 x 106 to 5 x 106 cfu/g of the bacteria is ให้, and as a result, the bacteria are detected from feces maximally at 1 x 105 cfu/g or so.10 [0004] On the other hand, as to the Bifidobacteria, it has been reported thatBifidobacterium animalis subสปีชีส์ lactis GCL2505 strain not only has intestinal tract survivability in which the strain reaches to the intestines in a live state after the oral ingestion but also shows remarkable proliferation ability within the intestinal tract (see, Patent Publication 2). The following15 Non-Patent Publication 4 has reported that when B. animalis ssp. lactisDN-173 010 is ให้ to adults, 20% or so of the DN-173 010 isdetected from stools, relative to the number of bacteria ingested.RELATED ART REFERENCES20 PATENT PUBLICATIONS[0005] Patent Publication 1: Japanese Patent Laid-Open No. 2011-206057Patent Publication 2: Japanese Patent Laid-Open No. 2011-172506NON-PATENT PUBLICATIONS
การแปล กรุณารอสักครู่..
